Esperion to Participate in BTIG Virtual Biotechnology Conference 2023
July 24 2023 - 8:00AM
Esperion (NASDAQ: ESPR) today announced its participation in the
BTIG Virtual Biotechnology Conference 2023. Ben Halladay, Chief
Financial Officer, will participate in a fireside chat on Monday,
August 7, 2023 at 9:00 AM ET. The Esperion management team will
also host investor meetings that same day.
Esperion TherapeuticsAt Esperion, we discover,
develop, and commercialize innovative medicines to help improve
outcomes for patients with or at risk for cardiovascular and
cardiometabolic diseases. The status quo is not meeting the health
needs of millions of people with high cholesterol – that is why our
team of passionate industry leaders is breaking through the
barriers that prevent patients from reaching their goals. Providers
are moving toward reducing LDL-cholesterol levels as low as
possible, as soon as possible; we provide the next steps to help
get patients there. Because when it comes to high cholesterol,
getting to goal is not optional. It is our life’s work. For more
information, visit esperion.com and esperionscience.com and follow
us on Twitter at twitter.com/EsperionInc.
Esperion Contact
Information: Investors:Alexis
Callahaninvestorelations@esperion.com(406) 539-1762
Media:Tiffany Aldrichcorporateteam@esperion.com(616)
443-8438
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From May 2024 to Jun 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2023 to Jun 2024